Miller Anestesia

149. Kang HK, Jeong YY, Choi JH, et al: Three-dimensio-

nal multi-detector row CT portal venography in the

evaluation of portosystemic collateral vessels in

liver cirrhosis. Radiographics 22:1053, 2002.

150. Kaplowitz N: Mechanisms of liver cell injury.

J Hepatol 32:39, 2000.

151. Nielsen VG, McCammon AT, Tan S, et al: Xanthine

oxidase inactivation attenuates postocclusion shock

after descending thoracic aorta occlusion and

reperfusion in rabbits. J Thorac Cardiovasc Surg

110:715, 1995.

152. Jaeschke H, Gores GJ, Cederbaum AI, et al: Mecha-

nisms of hepatotoxicity. Toxicol Sci 65:166, 2002.

153. Carden DL,Granger DN: Pathophysiology of ischae-

mia-reperfusion injury. J Pathol 190:255, 2000.

154. Arai M, Thurman RG, Lemasters JJ: Ischemic pre-

conditioning of rat livers against cold storage–

reperfusion injury: Role of nonparenchymal cells

and the phenomenon of heterologous preconditio-

ning. Liver Transpl 7:292, 2001.

155. Weinbroum A, Nielsen VG, Tan S, et al: Liver ische-

mia-reperfusion increases pulmonary permeability

in rat: Role of circulating xanthine oxidase. Am J

Physiol 268:G988, 1995.

156. Kaplowitz N, Tsukamoto H: Oxidative stress and

liver disease. Prog Liver Dis 14:131, 1996.

157. Ursini F, Maiorino M, Roveri A: Phospholipid

hydroperoxide glutathione peroxidase (PHGPx):

More than an antioxidant enzyme? Biomed Environ

Sci 10:327, 1997.

158. Doroshow JH, Akman S, Chu FF, et al: Role of the

glutathione–glutathione peroxidase cycle in the

cytotoxicity of the anticancer quinones. Pharmacol

Ther 47:359, 1990.

159. Michiels C, Raes M, Toussaint O, et al: Importance

of Se-glutathione peroxidase, catalase, and Cu/

Zn-SOD for cell survival against oxidative stress.

Free Radic Biol Med 17:235, 1994.

160. Luo GM, Ren XJ, Liu JQ, et al: Towards more effi-

cient glutathione peroxidase mimics: Substrate

recognition and catalytic group assembly. Curr Med

Chem 10:1151, 2003.

161. Kim JS, Qian T, Lemasters JJ: Mitochondrial per-

meability transition in the switch from necrotic to

apoptotic cell death in ischemic rat hepatocytes.

Gastroenterology 124:494, 2003.

162. Sawaya DE Jr, Brown M, Minardi A, et al: The role

of ischemic preconditioning in the recruitment of

rolling and adherent leukocytes in hepatic venules

after ischemia/reperfusion. J Surg Res 85:163,

1999.

163. Kurose I, Argenbright LW, Wolf R, et al: Ischemia/

reperfusion-induced microvascular dysfunction:

Role of oxidants and lipid mediators. Am J Physiol

272:H2976, 1997.

164. Yokoyama Y, Beckman JS, Beckman TK, et al: Cir-

culating xanthine oxidase: Potential mediator of

ischemic injury. Am J Physiol 258:G564, 1990.

165. Nielsen VG, Tan S,Weinbroum A, et al: Lung injury

after hepatoenteric ischemia-reperfusion: Role of

xanthine oxidase. Am J Respir Crit Care Med

154:1364, 1996.

166. Nielsen VG, Tan S, Baird MS, et al: Gastric intramu-

cosal pH and multiple organ injury: Impact of

ischemia-reperfusion and xanthine oxidase. Crit

Care Med 24:1339, 1996.

167. NielsenVG,Tan S,Baird MS,et al: Xanthine oxidase

mediates myocardial injury after hepatoenteric

ischemia-reperfusion. Crit Care Med 25:1044,

1997.

168. Nielsen VG, Tan S, Kirk KA, et al: Halothane and

xanthine oxidase increase hepatocellular enzyme

release and circulating lactate after ischemia-reper-

fusion in rabbits. Anesthesiology 87:908, 1997.

169. NielsenVG,Tan S,BrixAE,et al: Hextend (hetastarch

solution) decreases multiple organ injury and xan-

thine oxidase release after hepatoenteric ischemia-

reperfusion in rabbits. Crit Care Med 25:1565,

1997.

170. Pesonen EJ, Linder N, Raivio KO, et al: Circulating

xanthine oxidase and neutrophil activation during

human liver transplantation. Gastroenterology

114:1009, 1998.

171. Tan S, Yokoyama Y, Dickens E, et al: Xanthine

oxidase activity in the circulation of rats following

hemorrhagic shock. Free Radic Biol Med 15:407,

1993.

172. Radi R, Rubbo H, Bush K, et al: Xanthine oxidase

binding to glycosaminoglycans: Kinetics and supe-

roxide dismutase interactions of immobilized xan-

thine oxidase–heparin complexes. Arch Biochem

Biophys 339:125, 1997.

173. Adachi T, Fukushima T, Usami Y, et al: Binding of

human xanthine oxidase to sulphated glycosamino-

glycans on the endothelial-cell surface. Biochem J

289:523, 1993.

174. Beckman JS, Koppenol WH: Nitric oxide, supe-

roxide, and peroxynitrite: The good, the bad, and

ugly. Am J Physiol 271:C1424, 1996.

175. Toledo-Pereyra LH: Liver preservation: Experimen-

tal and clinical observations. Transplant Proc

20:965, 1988.

176. Jamieson NV, Sundberg R, Lindell S, et al: The 24- to

48-hour preservation of canine liver by simple cold

storage using UW lactobionate solution. Transplant

Proc 21:1292, 1989.

177. Marsh DC,Vreugdenhil PK, Mack VE, et al: Glycine

protects hepatocytes from injury caused by anoxia,

cold ischemia and mitochondrial inhibitors, but not

injury caused by calcium ionophores or oxidative

stress. Hepatology 17:91, 1993.

178. Adkison D, Hollwarth ME, Benoit JN, et al: Role of

free radicals in ischemia-reperfusion injury to the

liver. Acta Physiol Scand 548:101, 1986.

179. Jaeschke H, Lemasters JJ: Apoptosis versus oncotic

necrosis in hepatic ischemia/reperfusion injury.

Gastroenterology 125:1246, 2003.

180. Sindram D, Rudiger HA, Upadhya AG, et al: Ische-

mic preconditioning protects against cold ischemic

injury through an oxidative stress dependent

mechanism. J Hepatol 36:78, 2002.

181. Lehnert M, Arteel GE, Smutney OM, et al: Depen-

dence of liver injury after hemorrhage/resuscitation

in mice on NADPH oxidase–derived superoxide.

Shock 19:345, 2003.

182. Schemmer P, Connor HD, Arteel GE, et al: Reper-

fusion injury in livers due to gentle in situ organ

manipulation during harvest involves hypoxia and

free radicals. J Pharmacol Exp Ther 290:235,

1999.

183. Lee YG, Lee SH, Lee SM: Role of Kupffer cells in

cold/warm ischemia-reperfusion injury of rat liver.

Arch Pharmacol Res 23:620, 2000.

184. Schauer RJ, Bilzer M, Kalmuk S, et al: Microcircu-

latory failure after rat liver transplantation is related

to Kupffer cell–derived oxidant stress but not invol-

ved in early graft dysfunction. Transplantation

72:1692, 2001.

185. Radi R, Cassina A, Hodara R: Nitric oxide and

peroxynitrite interactions with mitochondria. Biol

Chem 383:401, 2002.

186. Warle MC, Farhan A, Metselaar HJ, et al: In vitro

cytokine production of TNF

and IL-13 correlates

with acute liver transplant rejection. Hum Immunol

62:1258, 2001.

187. Imamura H, Sutto F, Brault A, et al: Role of Kupffer

cells in cold ischemia/reperfusion injury of rat liver.

Gastroenterology 109:189, 1995.

188. Kerkweg U, Jacob M, De Groot H, et al: Cold-indu-

ced apoptosis of rat liver endothelial cells: Contri-

butionof mitochondrialalterations.Transplantation

76:501, 2003.

189. Doeppner TR, Grune T, de Groot H, et al: Cold-

induced apoptosis of rat liver endothelial cells:

Involvement of the proteasome. Transplantation

75:1946, 2003.

190. Sindram D, Porte RJ, Hoffman MR, et al: Platelets

induce sinusoidal endothelial cell apoptosis upon

reperfusion of the cold ischemic rat liver. Gastroen-

terology 118:183, 2000.

191. Lemasters JJ,Thurman RG: Reperfusion injury after

liver preservation for transplantation. Annu Rev

Pharmacol Toxicol 37:327, 1997.

192. Shedlofsky SI, Israel BC, McClain CJ, et al: Endo-

toxin administration to humans inhibits hepatic

cytochrome P450–mediated drug metabolism.

J Clin Invest 94:2209, 1994.

193. Gerson RJ, Casini A, Gilfor D, et al: Oxygen-media-

ted cell injury in the killing of cultured hepatocytes

by acetaminophen. Biochem Biophys Res Commun

126:1129, 1985.

194. Casini A, Giorli M, Hyland RJ, et al: Mechanisms of

cell injury in the killing of cultured hepatocytes by

bromobenzene. J Biol Chem 257:6721, 1982.

195. Tang W, Stearns RA, Bandiera SM, et al: Studies on

cytochrome P-450–mediated bioactivation of diclo-

fenac in rats and in human hepatocytes: Identifica-

tion of glutathione conjugated metabolites. Drug

Metab Dispos 27:365, 1999.

196. Wang M, Dickinson RG: Disposition and covalent

binding of diflunisal and diflunisal acyl glucuronide

in the isolated perfused rat liver.Drug Metab Dispos

26:98, 1998.

197. Tang W, Borel AG, Abbott FS: Conjugation of glu-

tathione with a toxic metabolite of valproic acid,

(E)-2-propyl-2,4-pentadienoic acid,catalyzed by rat

hepatic glutathione-

-transferases. Drug Metab

Dispos 24:436, 1996.

198. Patel T: Apoptosis in hepatic pathophysiology. Clin

Liver Dis 4:295, 2000.

199. Fau D, Lekehal M, Farrell G, et al: Diterpenoids

from germander, an herbal medicine, induce apop-

tosis in isolated rat hepatocytes. Gastroenterology

113:1334, 1997.

200. Haouzi D, Lekehal M, Moreau A, et al: Cytochrome

P450–generated reactive metabolites cause mito-

chondrial permeability transition, caspase activa-

tion, and apoptosis in rat hepatocytes. Hepatology

32:303, 2000.

201. Lewis W, Dalakas MC: Mitochondrial toxicity of

antiviral drugs. Nat Med 1:417, 1995.

202. Gut J, Christen U, Huwyler J, et al: Molecular

mimicry of trifluoroacetylated human liver protein

adducts by constitutive proteins and immunoche-

mical evidence for its impairment in halothane

hepatitis. Eur J Biochem 210:569, 1992.

203. Kretz-Rommel A, Boelsterli UA: Cytotoxic acti-

vity of T cells and non-T cells from diclofenac-

immunized mice against cultured syngeneic

hepatocytes exposed to diclofenac. Hepatology

22:213, 1995.

204. Bourdi M, Larrey D, Nataf J, et al: Anti-liver endo-

plasmic reticulum autoantibodies are directed

against human cytochrome P-450IA2. A specific

marker of dihydralazine-induced hepatitis. J Clin

Invest 85:1967, 1990.

205. Lecoeur S,Bonierbale E,Challine D,et al: Specificity

of in vitro covalent binding of tienilic acid metabo-

lites to human liver microsomes in relationship to

the type of hepatotoxicity: Comparison with two

directly hepatotoxic drugs. Chem Res Toxicol 7:434,

1994.

204

Fisiología y anestesia